Type of financial instrument | Financial instrument | ISIN code | Nature of transaction | Linked to the exercise of a share option programme | Volume | Unit | Price per unit | Currency code | Transaction date | Place of the transaction |
---|---|---|---|---|---|---|---|---|---|---|
BTU | Elicera Therapeutics AB BTU | SE0021626306 | Subscription | 21,700 | Quantity | 16.20 | SEK | 08/03/2024 | NASDAQ STOCKHOLM AB | |
Subscription right/Unit right | Elicera Therapeutics AB UR | SE0021626298 | Acquisition | 64,500 | Quantity | 0.0183 | SEK | 26/02/2024 | NASDAQ STOCKHOLM AB | |
Subscription right/Unit right | Elicera Therapeutics AB UR | SE0021626298 | Acquisition | 31,000 | Quantity | 0.0051 | SEK | 04/03/2024 | NASDAQ STOCKHOLM AB | |
Subscription right/Unit right | Elicera Therapeutics AB UR | SE0021626298 | Disposal | 500,000 | Quantity | 0.0024 | SEK | 01/03/2024 | NASDAQ STOCKHOLM AB | |
Subscription right/Unit right | Elicera Therapeutics AB UR | SE0021626298 | Disposal | 1,687,000 | Quantity | 0.00159 | SEK | 04/03/2024 | NASDAQ STOCKHOLM AB |
Financial instrument | ISIN code | Nature of transaction | Transaction date | Place of the transaction | Volume | Weighted average price |
---|---|---|---|---|---|---|
Elicera Therapeutics AB BTU | SE0021626306 | Subscription | 08/03/2024 | NASDAQ STOCKHOLM AB | 21,700 (Quantity) | 16.20 SEK |
Elicera Therapeutics AB UR | SE0021626298 | Acquisition | 26/02/2024 | NASDAQ STOCKHOLM AB | 64,500 (Quantity) | 0.0183 SEK |
Elicera Therapeutics AB UR | SE0021626298 | Acquisition | 04/03/2024 | NASDAQ STOCKHOLM AB | 31,000 (Quantity) | 0.0051 SEK |
Elicera Therapeutics AB UR | SE0021626298 | Disposal | 01/03/2024 | NASDAQ STOCKHOLM AB | 500,000 (Quantity) | 0.0024 SEK |
Elicera Therapeutics AB UR | SE0021626298 | Disposal | 04/03/2024 | NASDAQ STOCKHOLM AB | 1,687,000 (Quantity) | 0.00159 SEK |